Additional studies are warranted to investigate the molecular mechanisms that underlie the beneficial effects of pentoxifylline against mania-like and depression-like behavior in animals, including the mitogen-activated protein kinases and nuclear factor kappa B pathways. The gene discussed is WNK2; the disease is major depressive disorder.